top of page

3rd UK and Ireland Blood-Brain Barrier Symposium

medimmune.jpg
Dr Carl Webster was the host for 3rd UK & Ireland Early Career BBB Symposium. The BBB Symposium was held on the 22st of November 2013 at MedImmune, Cambridge, UK . The keynote presentation for this symposium was given by Dr Iain Chessell, Vice President Neuroscience, MedImmune. The symposium program is listed below:

 

10.15-11.00:                          Registration and Refreshments
 
11.00-11.45:                          Keynote Session
                                                        The promise of crossing the blood brain barrier: challenges and progress. Iain Chessell, VP Neurosciences, MedImmune
​
11.45-12.45:                          Session 1
​
                                                        The secondary effect of Plasmodium falciparum infected red blood cells (PRBC) sequestration on blood-brain barrier (BBB)                                                             permeability in cerebral malaria (CM) an in-vitro study. Mohd Hamzah Mohd Nasir, Keele University
 
                                                        Contribution of the blood brain barrier (BBB) in neuro-immune communication following bacterial infection. Ursula                                                                             Püntener, University of Southampton
​
                                                        CD4+ T cells and inflammatory cytokines potentiate Hepatitis C virus infection of the BBB. Nichola Fletcher, Birmingham                                                                 University
 
12.45-13.45:                           Lunch and Poster Session
 
13:45-15:05:                          Session 2
​
                                                        Brain endothelial miR146a inhibits leucocyte adhesion through targeting NFAT5. Dongsheng Wu, Open University
 
                                                        Selective permeabilisation of the blood-brain barrier at sites of metastasis. John Connell, Oxford University
 
                                                        P-glycoprotein inhibition as a strategy to augment antidepressant delivery across the blood-brain barrier: preclinical                                                                           pharmacokinetic and pharmacodynamic studies. Fionn O’Brien, University College Cork
 
                                                        Regional heterogeneity in the endothelial glycocalyx and basement membrane of the retinal vasculature. Marie O’Connor,                                                              Institute of Ophthalmology
​
15.05-15.30:                          Refreshments and posters
 
15:30-18.00:                          Session 3
 
                                                        Small gold nanoparticles: potential carriers of therapeutics across the blood-brain barrier. Radka Gromnicova Open                                                                              University
​
                                                        Chemically functionalised carbon nanotubes as potential vectors for brain delivery in vivo. Julie Wang, Kings College,                                                                          London
​
                                                        Modelling the Transport of Nanoparticles across the Blood‐Brain Barrier.  Gavin Fullstone, UCL
​
                                                        Making the transfer from Academic to Industry: Success in the recruitment process. Dinesh Chauhan, The Right Thing
 
                                                        Careers in industry, Lutz Jermutus, Senior Director, MedImmune
 
Poster Presentations
​
Abraham S, UCL
Inês Sá-Pereira, University of Oxford
C. Wang, Open University
Sophie Nyborg, UCL
Zerin Alimajstorovic, Open University
bottom of page